Company intelligence / Profile preview

Sutura Medical Technology

Boca Raton, Florida, United Statesnovathreads.us ↗

Ownership: Private
Development stage: Commercial

Overview

The company sponsored a pivotal, blinded multi-center clinical trial (NCT06404372) to assess the safety and effectiveness of the Demetech Barbed PDO Suture for temporary treatment of midface wrinkles. The study enrolled 57 subjects and evaluated wrinkle improvement over 12 months using the Lemperle Classification Facial Wrinkle Scale. Primary endpoints included adverse event rates and significant wrinkle reduction at 6 months; secondary endpoints focused on longer-term results and patient satisfaction. The trial has been completed.

Therapeutic areas: Dermatology
Modalities: DeviceAbsorbable suture
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Sutura Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sutura Medical Technology.

Explore the full profile